LIP
JAZZ icon

Lighthouse Investment Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Lighthouse Investment Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.61M Sell
15,000
-18,727
-56% -$4.1M 0.1% 257
2026
Q1 		$6.38M Buy
+33,727
New +$5.89M 0.22% 153
2025
Q1 		– Sell
-24,500
Closed -$3.02M – 560
2024
Q4 		$3.02M Buy
+24,500
New +$2.89M 0.1% 236

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Lighthouse Investment Partners's JAZZ Position: Q2 2026 in Review

Lighthouse Investment Partners reduced its Jazz Pharmaceuticals (JAZZ) stake by 56% in Q2 2026, selling an estimated $4.1M and leaving 15,000 shares worth $3.61M. The position accounts for 0.1% of the portfolio, ranked #257.

Lighthouse Investment Partners first reported a position in JAZZ in Q4 2024 and has held it in 3 quarters since. The position peaked at $6.38M in Q1 2026. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Lighthouse Investment Partners held 15,000 shares of Jazz Pharmaceuticals worth $3.61M as of Q2 2026.
  • Lighthouse Investment Partners sold 18,727 Jazz Pharmaceuticals shares in Q2 2026, an estimated $4.1M.
  • Jazz Pharmaceuticals made up 0.1% of Lighthouse Investment Partners's portfolio in Q2 2026, its #257 holding.
  • Lighthouse Investment Partners first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Lighthouse Investment Partners's Jazz Pharmaceuticals position peaked at $6.38M in Q1 2026.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.